These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5351601)

  • 1. The intravenous galactose test as indicator in the extent of fibrosis in patients with cirrhosis of the liver.
    Myren J; Kierulf P
    Scand J Gastroenterol; 1969; 4(5):453-6. PubMed ID: 5351601
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intravenous galactose-tolerance test in liver cirrhosis. A comparison with bromsulfalein leading].
    Järnerot G
    Nord Med; 1970 Dec; 84(50):1586-8. PubMed ID: 5519422
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the indices of the bromsulphalein test, the serum cholinesterase and the galactose test by hepatic cirrhosis.
    Mincev M
    Folia Med (Plovdiv); 1974; 16(3):151-6. PubMed ID: 4216552
    [No Abstract]   [Full Text] [Related]  

  • 4. On the diagnostic and prognostic value of the bromsulphthalein test in patients with hepatic cirrhosis.
    Mincev M
    Folia Med (Plovdiv); 1971; 13(4):225-30. PubMed ID: 5003939
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative evaluation of tolerance tests with sulfobromophthalein and with galactose in chronic liver diseases. (Value and limitations of the discriminating analyses used in the 2 tests for diagnosis of hepatic cirrhosis)].
    Coltorti M; Di Simone A; Budillon G; Carrella M; Oriani G
    Policlinico Med; 1968; 75(4):189-215. PubMed ID: 5708459
    [No Abstract]   [Full Text] [Related]  

  • 6. Radioimmunoassay of serum bile acid levels in biopsy-proved cirrhosis.
    Dasher CA; Hirschowitz BI; Spenney JG; Gibson RG; Mihas AA
    South Med J; 1977 Aug; 70(8):968-9, 973. PubMed ID: 887983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intravenous galactose tolerance test with an enzymatic determination of galactose. A comparison with other diagnostic aids in hepatobiliary diseases.
    Tengström B
    Scand J Clin Lab Invest Suppl; 1966; 18():132-42. PubMed ID: 5958513
    [No Abstract]   [Full Text] [Related]  

  • 8. The bromsulphalein and galactose tolerance tests in patients with various liver diseases. A comparative study.
    den Blaauwen DH; Thijs LG
    Acta Gastroenterol Belg; 1973; 36(7):345-75. PubMed ID: 4751674
    [No Abstract]   [Full Text] [Related]  

  • 9. THE GALACTOSE ELIMINATION CAPACITY IN RELATION TO CLINICAL AND LABORATORY FINDINGS IN PATIENTS WITH CIRRHOSIS.
    TYGSTRUP N
    Acta Med Scand; 1964 Mar; 175():291-300. PubMed ID: 14136244
    [No Abstract]   [Full Text] [Related]  

  • 10. [Liver function test after nicotinic acid loading. I. A clinical study].
    Finck C; Jorke D
    Acta Hepatosplenol; 1968; 15(5):315-21. PubMed ID: 5707324
    [No Abstract]   [Full Text] [Related]  

  • 11. [Examination of intravenous galactose loading test].
    Shiga O; Kato K; Kikuchi S
    Rinsho Byori; 1971 Aug; 19():Suppl:389. PubMed ID: 5168076
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of the bromsulphthalein and galactose elimination test in patients with either chronic bowel inflammation or alcoholic liver disease.
    Nilsson LH; Hultman E
    Scand J Gastroenterol; 1974; 9(3):319-23. PubMed ID: 4850181
    [No Abstract]   [Full Text] [Related]  

  • 13. The discriminant diagnostic power of liver function tests in hepatic cirrhosis.
    Serra MA; Rodrigo JM; Guix J; Montes F; Wassel A; Aparisi L; Olmo JA; Bixquert M
    Acta Med Port; 1981; 3(1):3-10. PubMed ID: 7304266
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serologic diagnosis of liver fibrosis].
    Sauerbruch T
    Dtsch Med Wochenschr; 1999 Oct; 124(41):1191. PubMed ID: 10572514
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thrombocytopenia and liver cirrhosis].
    Frick W
    Schweiz Med Wochenschr; 1967 Apr; 97(13):407-13. PubMed ID: 4174227
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of a differential functional pattern between non-cirrhotic chronic liver disease and hepatic cirrhosis: a multivariate approach.
    Coltorti M; Colombi A; Lucchelli PE; Budillon G; Di Simone A; Carrella M; Oriani GA
    Rev Int Hepatol; 1969; 19(7):451-73. PubMed ID: 4102238
    [No Abstract]   [Full Text] [Related]  

  • 17. [KINETICS OF RIFAMYCIN SV, EXCRETION OF BROMSULPHALEIN AND BILIRUBINEMIA: EXPERIMENTS IN HUMANS].
    ACOCELLA G; BARONI GC; NICOLIS FB; TENCONI LT
    Chemotherapia (Basel); 1963; 12():401-8. PubMed ID: 14185764
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and chemical course control of liver cirrhosis].
    Strohmeyer G; Dölle W; Martini GA
    Fortschr Med; 1973 Oct; 91(29):1140-4. PubMed ID: 4270664
    [No Abstract]   [Full Text] [Related]  

  • 19. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tolerance of galactose and bromsulfthalein in liver cirrhosis. A comment to a reply].
    Järnerot G
    Nord Med; 1971 Mar; 85(11):351-2. PubMed ID: 5553213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.